200 related articles for article (PubMed ID: 37622089)
1. A combination treatment of low-dose dexamethasone and aspirin-triggered resolvin D1 reduces Sjögren syndrome-like features in a mouse model.
Dos Santos HT; Maslow F; Nam K; Trump B; Weisman GA; Baker OJ
JADA Found Sci; 2023; 2():. PubMed ID: 37622089
[TBL] [Abstract][Full Text] [Related]
2. Aspirin-Triggered Resolvin D1 Versus Dexamethasone in the Treatment of Sjögren's Syndrome-Like NOD/ShiLtJ Mice - A Pilot Study.
Easley JT; Nelson JW; Mellas RE; Sommakia S; Wu C; Trump B; Baker OJ
J Rheum Dis Treat; 2015; 1(4):. PubMed ID: 27110599
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
Dean S; Wang CS; Nam K; Maruyama CL; Trump BG; Baker OJ
Rheumatology (Oxford); 2019 Jul; 58(7):1285-1292. PubMed ID: 30877775
[TBL] [Abstract][Full Text] [Related]
4. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.
Easley JT; Maruyama CL; Wang CS; Baker OJ
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694530
[TBL] [Abstract][Full Text] [Related]
5. AT-RvD1 Promotes Resolution of Inflammation in NOD/ShiLtJ mice.
Wang CS; Maruyama CL; Easley JT; Trump BG; Baker OJ
Sci Rep; 2017 Mar; 7():45525. PubMed ID: 28361884
[TBL] [Abstract][Full Text] [Related]
6. Predictive modeling of aspirin-triggered resolvin D1 pharmacokinetics for the study of Sjögren's syndrome.
Yellepeddi VK; Baker OJ
Clin Exp Dent Res; 2020 Apr; 6(2):225-235. PubMed ID: 32250566
[TBL] [Abstract][Full Text] [Related]
7. Expression of resolvin D1 biosynthetic pathways in salivary epithelium.
Leigh NJ; Nelson JW; Mellas RE; Aguirre A; Baker OJ
J Dent Res; 2014 Mar; 93(3):300-5. PubMed ID: 24389810
[TBL] [Abstract][Full Text] [Related]
8. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.
Parashar K; Schulte F; Hardt M; Baker OJ
FASEB J; 2020 Jun; 34(6):7733-7744. PubMed ID: 32277856
[TBL] [Abstract][Full Text] [Related]
9. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.
Dos Santos HT; Nam K; Maslow F; Trump B; Baker OJ
Ann Diagn Pathol; 2022 Feb; 56():151865. PubMed ID: 34847389
[TBL] [Abstract][Full Text] [Related]
10. Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically-Based Pharmacokinetic Modeling.
Yellepeddi VK; Parashar K; Dean SM; Watt KM; Constance JE; Baker OJ
Clin Transl Sci; 2021 Mar; 14(2):683-691. PubMed ID: 33202089
[TBL] [Abstract][Full Text] [Related]
11. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.
Nelson JW; Leigh NJ; Mellas RE; McCall AD; Aguirre A; Baker OJ
Am J Physiol Cell Physiol; 2014 Jan; 306(2):C178-85. PubMed ID: 24259417
[TBL] [Abstract][Full Text] [Related]
12. Changes in the Submandibular Salivary Gland Epithelial Cell Subpopulations During Progression of Sjögren's Syndrome-Like Disease in the NOD/ShiLtJ Mouse Model.
Gervais EM; Desantis KA; Pagendarm N; Nelson DA; Enger T; Skarstein K; Liaaen Jensen J; Larsen M
Anat Rec (Hoboken); 2015 Sep; 298(9):1622-34. PubMed ID: 26179322
[TBL] [Abstract][Full Text] [Related]
13. Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury.
Chen J; Shetty S; Zhang P; Gao R; Hu Y; Wang S; Li Z; Fu J
Toxicol Appl Pharmacol; 2014 Jun; 277(2):118-23. PubMed ID: 24709673
[TBL] [Abstract][Full Text] [Related]
14. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H
J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.
Rogerio AP; Haworth O; Croze R; Oh SF; Uddin M; Carlo T; Pfeffer MA; Priluck R; Serhan CN; Levy BD
J Immunol; 2012 Aug; 189(4):1983-91. PubMed ID: 22802419
[TBL] [Abstract][Full Text] [Related]
16. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
[TBL] [Abstract][Full Text] [Related]
17. Zonula occludens-1, occludin and E-cadherin expression and organization in salivary glands with Sjögren's syndrome.
Mellas RE; Leigh NJ; Nelson JW; McCall AD; Baker OJ
J Histochem Cytochem; 2015 Jan; 63(1):45-56. PubMed ID: 25248927
[TBL] [Abstract][Full Text] [Related]
18. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
20. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of non-obese diabetic mice.
Gatumu MK; Skarstein K; Papandile A; Browning JL; Fava RA; Bolstad AI
Arthritis Res Ther; 2009; 11(1):R24. PubMed ID: 19222863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
